Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-11-07

FDA Approved: BONJESTA — Original Application (Duchesnay USA, Inc.)

View source ↗

Summary

FDA approved Bonjesta (doxylamine succinate and pyridoxine hydrochloride) in an original application as an extended-release fixed-dose combination for nausea an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bonjesta (doxylamine succinate and pyridoxine hydrochloride)

Snippet

ORIG AP for BONJESTA (DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE)